Favipiravir, lopinavir-ritonavir, or combination therapy
Favipiravir, lopinavir-ritonavir, or combination therapy
About this item
Full title
Author / Creator
Lowe, David M , Brown, Li-An K , Chowdhury, Kashfia , Davey, Stephanie , Yee, Philip , Ikeji, Felicia , Ndoutoumou, Amalia , Shah, Divya , Lennon, Alexander , Rai, Abhulya , Agyeman, Akosua A , Checkley, Anna , Longley, Nicola , Dehbi, Hakim-Moulay , Freemantle, Nick , Breuer, Judith and Standing, Joseph F
Publisher
Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
Public Library of Science
Subjects
More information
Scope and Contents
Contents
Early antiviral treatment is effective for Coronavirus Disease 2019 (COVID-19) but currently available agents are expensive. Favipiravir is routinely used in many countries, but efficacy is unproven. Antiviral combinations have not been systematically studied. We aimed to evaluate the effect of favipiravir, lopinavir-ritonavir or the combination of...
Alternative Titles
Full title
Favipiravir, lopinavir-ritonavir, or combination therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss_ISR_A724756571
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_ISR_A724756571
Other Identifiers
ISSN
1549-1277
DOI
10.1371/journal.pmed.1004120
